SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)
Clinical trial NCT06401005 · RECRUITING
Trial details
- NCT number
- NCT06401005
- Sponsor
- Hubei Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-28
- Primary completion
- 2026-08-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.